WhaleCreepWhat the best hedge funds own, from their SEC 13F filings
HomeFundsValueAct Capital › Q2 2010

ValueAct Capital 13F holdings, Q2 2010

Holdings as of June 30, 2010 · filings on SEC EDGAR · latest filing →

ValueAct Capital disclosed 10 US equity positions worth $2.9bn in its Q2 2010 13F filing. The largest position was VALEANT PHARMACEUTICALS INTL at 27.3% of the reported book, followed by SARA LEE CORP and IT. Against the Q1 2010 filing, it opened 2 new positions, added to 4 and reduced 1 among the top 10 holdings.

← Q1 2010 · Q3 2010 →

What did ValueAct Capital own in Q2 2010? Top 10 positions

#StockSectorWeightValueSharesΔ sharesvs Q1 2010
1 VALEANT PHARMACEUTICALS INTL 27.3%$791.6m15,138,358 -15% reduced
2 SARA LEE CORP 17.0%$492.4m34,918,822 0% held
3 IT GARTNER GROUP INC NEW-CL A Technology 16.7%$483.4m20,790,013 0% held
4 VRSN VERISIGN INC Technology 10.4%$303.0m11,411,869 57% added
5 WILLIS GROUP HOLDINGS LTD 8.0%$231.9m7,717,510 new
6 C R BARD INC 7.9%$228.1m2,942,644 9% added
7 SNA SNAP ON TOOLS CORP Industrials 5.2%$149.5m3,653,638 109% added
8 IMMUCOR INC 5.0%$143.7m7,540,665 54% added
9 NBTY INC 1.7%$49.8m1,464,700 new
10 OPLN KAR AUCTION SERVICES INC Consumer Cyclical 1.0%$27.9m2,258,828 0% held

Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.